www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Healthcare firms to grasp CIIE opportunities

By HE WEI in Shanghai | China Daily | Updated: 2021-11-02 09:37
Share
Share - WeChat
Visitors check out the booth of Boston Scientific during the third China International Import Expo in Shanghai in 2020. [Photo/CHINA DAILY]

Expo will prove a great platform to publicize innovative tech, equipment and pharmaceuticals

All eyes may be on the China International Import Expo whose fourth edition will open this week. Who can resist such a grand fair that will spotlight flashy exhibits and novel solutions the world has to offer? Certainly not multinational medical companies operating in China. They are among the corporates that are riding China's favorable policies and vast market potential.

"Spillover effects" and "product debuts", executives said, are the main chords running through their participation themes for this year's CIIE.

After all, the nation of 1.4 billion people still faces unmet medical needs and is an avid advocate of, and a generous spender on, bolstering healthcare.

Beijing's grand Healthy China 2030 initiative aims to triple total healthcare expenditure from 2017 to 2030 to $2.5 trillion, and the sheer number and ambition spell heartening news to Ricardo Marek, president of Takeda's growth and emerging markets business unit.

"It presents an opportunity for us as we are set to launch more than 15 innovative medicines and Wave 1 pipelines over the next three to five years," Marek said.

An expert in oncology, rare diseases, gastroenterology, neuroscience and plasma-derived therapies, Japan-based Takeda is placing high hopes on China, which is projected to be the company's second-largest market by fiscal year 2031, thanks to an estimated 20 percent annual growth over the next five years.

"China speed", a term Marek used to refer to China's optimized new drug reviews and accelerated new drug approvals, will be reflected during the CIIE.

For instance, the new drug application of an oral innovative drug for lung cancer was given a priority review designation, leading to simultaneous submissions to National Drug Authority in China and globally. The product will be on display at the fourth CIIE.

"This will enable Takeda's innovative drug to benefit Chinese patients as early as possible," he said.

The CIIE offers a clue to some pioneering medical practices, conducting first-trial experiments and real-world research to help China's medical equipment sector, as is the case of US medical device company Boston Scientific.

For instance, at last year's CIIE, the company debuted a water vapor therapy as a minimally invasive treatment for benign prostatic hyperplasia. Later, the company performed the first such procedure at Hainan Boao Lecheng International Medical Tourism Pilot Zone-a dedicated area in which preferential policies allow the import of medical devices, technologies and drugs. This product will be officially pre-launched during the fourth CIIE.

Similarly, another product that debuted at the second CIIE for the treatment of unresectable hepatocellular carcinoma, has entered into a local partnership in Chengdu, capital of Sichuan province.

"We benefit from the 'multiplying' and 'acceleration' effects of the CIIE, with several of our previous exhibits turning into tangible products at an expedited speed," said June Chang, president of Boston Scientific China.

"The 'spillover effect' lies more in launching products at a fast pace rather than in mobilizing domestic and international resources to create new opportunities and new models."

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 成人欧美一区二区三区视频xxx | 国产成人啪精品午夜在线观看 | 久草视频在线资源站 | 国产性生活视频 | 久久久久一区二区三区 | 男人的亚洲天堂 | 国产亚洲精品国看不卡 | 精品欧美成人高清在线观看2021 | 99久久精品男女性高爱 | 高清不卡一区二区三区 | 国产美女一级视频 | 美女视频大全视频a免费九 美女视频大全网站免费 | 午夜dj视频完整社区 | 日韩免费三级 | 亚洲一区在线视频 | 蜜桃88av| 91亚洲精品一区二区福利 | 日韩精品无码一区二区三区 | 中日韩欧美一级毛片 | 午夜免费片在线观看不卡 | a级毛片免费高清毛片视频 a级毛片免费高清视频 | 91精品成人免费国产片 | 无国产精品白浆是免费 | 国产成人免费视频精品一区二区 | 91欧美在线 | 久久精品视频在线观看 | 精品国产一区二区三区四区vr | 91情侣高清精品国产 | 国产欧美日本在线观看 | 农村寡妇野外情一级毛片 | 美毛片 | 国产精品久久久久三级 | 91年精品国产福利线观看久久 | 久久久久亚洲视频 | 国产一区二区精品久 | 亚洲美女视频网站 | 国产99视频精品免视看9 | 欧美日韩亚洲第一页 | 久久久久久久国产精品毛片 | 日本欧美一区二区三区视频 | 亚洲国产精品日韩高清秒播 |